Eslicarbazepine Acetate (BIA 2-093): Relative Bioavailability and Bioequivalence of 50 mg/mL Oral Suspension and 200mg and 800mg Tablet Formulations

Author: Fontes-Ribeiro Carlos  

Publisher: Adis International

ISSN: 1174-5886

Source: Drugs in R&D, Vol.6, Iss.5, 2005-01, pp. : 253-260

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content